Tobias Welponer (T Welponer)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Locally Advanced

Systematic Review

Squamous Cell Carcinoma

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

The British journal of dermatology

The Journal of dermatological treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Tobias Welponer, Christine Prodinger, Eva W H Korte, Sjoukje van der Werf, Christine Prodinger, Marieke C Bolling, Martin Laimer
Systematic review on antipruritic therapies for patients with Epidermolysis bullosa. The Journal of dermatological treatment 35 (1) (2024)
Eva W H Korte, Anna Maria Gerdina Pasmooij, Marieke C Bolling, Sinéad Hickey, Sagair Hussain, Dimitra Kiritsi, Jan Kottner, Cecilia A C Prinsen, Angélique Sauvestre, Gaston Sendin, Phyllis I Spuls, Núria Tarrats, Verena Wally, Tobias Welponer, Martin Laimer, Peter C van den Akker, null null
Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa. The British journal of dermatology 191 (3) (2024)
Eva W H Korte, Anna Maria Gerdina Pasmooij, Marieke C Bolling, Sinéad Hickey, Sagair Hussain, Dimitra Kiritsi, Jan Kottner, Cecilia A C Prinsen, Angélique Sauvestre, Gaston Sendin, Phyllis I Spuls, Núria Tarrats, Verena Wally, Tobias Welponer, Martin Laimer, Peter C van den Akker, null null
Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa. The British journal of dermatology (2024)
Eva W H Korte, Phyllis I Spuls, Peter C van den Akker, Dimitra Kiritsi, Martin Laimer, Anna Maria Gerdina Pasmooij, Rainer Riedl, Elizabeth Vroom, Verena Wally, Tobias Welponer, Marieke C Bolling
Harmonization of outcomes in epidermolysis bullosa - report of the Core Outcome Sets for Epidermolysis Bullosa (COSEB) kick-off meeting. The British journal of dermatology (2023)
Roland Lang, Tobias Welponer, E Richtig, I Wolf, C Hoeller, C Hafner, V A Nguyen, J Kofler, M Barta, P Koelblinger, W Hitzl, M Emberger, M Laimer
Nivolumab for locally advanced and metastatic cutaneous squamous cell carcinoma (NIVOSQUACS study) - phase II data covering impact of concomitant hematological malignancies. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Tobias Welponer, D D Weber, L Trattner, B Tockner, S Aminzadeh-Gohari, V Leb-Reichl, A Kaufmann, R Zauner, M Wimmer, V Wally, T K Felder, D Strunk, U Koller, J W Bauer, B Kofler, C Guttmann-Gruber, J Piñon Hofbauer
Metformin shows anti-neoplastic properties by inhibition of oxidative phosphorylation and glycolysis in epidermolysis bullosa-associated aggressive cutaneous squamous cell carcinoma. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Damian Meyersburg, Tobias Welponer, Andreas Kaiser, Sylvia Selhofer, Rafaella Tatarski, Alessandra Handisurya, Johannes Wolfgang Bauer
Comparison of topical benzyl benzoate vs. oral ivermectin in treating scabies: A randomized study. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)